Related Experiment Videos

Effective use of supplemental nurses

Health Services Manager

|October 9, 1979

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000

Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185.

International journal of cancer·1999

Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998

Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissues.

Hybridoma·1998

A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein.

Biological chemistry·1998

The binding of receptor-recognized alpha2-macroglobulin to the low density lipoprotein receptor-related protein and the alpha2M signaling receptor is decoupled by oxidation.

The Journal of biological chemistry·1997

See all related articles